Aoki Masaya, Hirono Keiichi, Higuma Tomonori, Suzuki Yoko, Nakayama Kazuhiko, Yamashita Akio, Fukahara Kazuaki, Ichida Fukiko, Emoto Noriaki, Yoshimura Naoki
Department of Cardiovascular Surgery, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Department of Pediatrics, University of Toyama, Toyama, Japan.
Gen Thorac Cardiovasc Surg. 2018 May;66(5):299-302. doi: 10.1007/s11748-017-0809-6. Epub 2017 Aug 10.
It is well known that Down's syndrome is a strong risk factor for mortality after Fontan operations. We performed two lung biopsies in a Down's syndrome patient who underwent staged Fontan operations. The pathological findings revealed severe pulmonary arterial hypertrophy and a quantitative real-time polymerase chain reaction revealed the overexpression of endothelin and a decline in the eNOS level at the Fontan operation. Although the preoperative hemodynamic studies revealed that all of the criteria for Fontan had been fulfilled, the patient died of acute cardiac insufficiency, 35 days after the Fontan operation.
众所周知,唐氏综合征是Fontan手术后死亡的一个重要风险因素。我们对一名接受分期Fontan手术的唐氏综合征患者进行了两次肺活检。病理检查结果显示严重的肺动脉肥厚,实时定量聚合酶链反应显示在Fontan手术时内皮素过表达且内皮型一氧化氮合酶水平下降。尽管术前血流动力学研究显示所有Fontan手术标准均已满足,但该患者在Fontan手术后35天死于急性心功能不全。